The U.S. complex & chronic condition management market was valued at US$ 3.2 billion in 2021 and is expected to reach over US$ 8.7 billion by 2027, with a registered CAGR of 18% during forecast period 2021 to 2027.
Access our Premium Real Time Data Intelligence Tool, Visit: Precedence Statistics
Chronic condition means patients living with the chronic diseases for years and the affected cells progress over time. The chronic diseases are the major revenue contributors to the healthcare industry. Complex & chronic condition management is a program that helps the patients and the healthcare professionals to improve the healthcare services and improve the patient’s quality of life. The chronic condition management services provide support to the patients from different medical services. The proliferation of digital technologies has encouraged the development of the telehealth industry. The rapid adoption of the telehealth services among both the healthcare professionals and consumers is the primary driver of the US complex & chronic condition management market.
Around half of the US population is suffering from at least one chronic disease. The most prominent chronic diseases in US are cardiovascular diseases, cancer, COPD, diabetes, and musculoskeletal disorders. These chronic diseases are the major causes of death in US. The rising prevalence of various chronic diseases coupled with the increasing healthcare expenditure is estimated to spur the demand for the innovative and advanced complex & chronic condition management services.Growing geriatric population is another major factor that highly influences the market growth. The geriatric population in US is rapidly growing. Moreover, the old age people are more prone to the chronic diseases and tend to spend more on their health. Therefore, the growing geriatric population coupled with the rising healthcare expenditure is expected to significantly foster the market growth during the forecast period.
Scope of the U.S. Complex and Chronic Condition Management Market
|Market Size In 2020||US$ 2.7 Billion|
|Growth Rate From 2021 to 2027||CAGR of 18%|
|Revenue Projection in 2027||US$ 8.7 Billion|
|Forecast Period||2021 To 2027|
|Fastest Growing Market||United State|
|Segments Covered||Service, Disease Type, Region|
|Companies Mentioned||AllScripts, Siemens Healthineers, Koninklijke Philips N.V., Pegasystems, Inc., Cognizant TriZetto Software Group Inc., IBM Corporation, ScienceSoft USA, MINES & Associates, Inc., Healthcare at Home, Mediware Information Systems|
Disease Type Insights
Cardiovascular diseases accounted for the largest market share at 28.6% in 2020, and this trend is expected to continue over the projected period.The increased prevalence of cardiovascular diseases in US is the primary contributor to the growth of the complex and chronic condition management market. The proliferation of the digital technologies and development of advanced software systems has enabled a systematic care delivery in the US healthcare sector, which helps the patients to avoid any exacerbations and complications. The complex and chronic condition management solution connects the patients devices like smartphones and tablets with the electronic health records (EHR) through an app installed in the patients’ device. This solutions analyses the cardiovascular health of the patient, processes the information, and provides alerts and notifications that helps in the timely diagnosis and treatment. The complex and chronic condition management solution and the mobile app serve as a crucial communication point between the caregiver and the patient.
Chronic Obstructive Pulmonary Disease (COPD)are expected to witness maximum gains over the forecast period due to rising patient preference for the complex and chronic condition management services for the COPD condition management. Moreover, the rising prevalence of the COPD among the US population is boosting the growth. It is estimated that around 14.8 million adults in US have been diagnosed with COPD in 2020.
The implementation services segment dominated the complex and chronic condition management market in US. The telehealth service providers play a crucial role in connecting the patients and the care providers. The arrangements are done by the service providers when a patient requires visiting a clinic or a hospital to acquire therapies and tests. The increased prevalence of various chronic diseases that frequently requires implementation services has fostered the growth of this segment. The patients suffering from the diseases such as cancer, reproductive disorder, and musculoskeletal disorders regularly needs the in-person care for receiving various therapies and conduct tests. Therefore, the implementation services have captured a huge market share owing to its higher revenue generation.
The education services are expected to be the fastest-growing segment. The education services are necessary for various patients who are suffering from COPD and different musculoskeletal conditions. The necessity for gaining information regarding the management of certain health conditions is driving the growth of the education services. The health education service providers are increasingly adopting the digital technologies for reaching out to the consumers. The education services play a major role in the self-management of chronic conditions.
US witnessed a rapid surge in the adoption of the telehealth and chronic condition management services during the pandemic owing to the lockdown restrictions. Moreover, the risks of getting infected with the COVID-19 diseases forced people to stay at their homes. This situation increased the adoption of the chronic condition management solutions among the patients who are suffering from one or more chronic diseases. The telehealth services helped the patients to take good care of their health and avoid any negative consequences due to the delayed care.
Moreover, the growth of the telehealth and chronic care management was fueled by the presence of strong telecommunications and IT infrastructure. The majority of the population had access to smartphones and internet that boosted growth of the complex & chronic condition management market in US. This trend is expected to continue during the forecast period and the US & chronic condition market is expected to witness a rapid surge throughout the forecast period.
In 2020, Allscripts announced a definitive agreement to sell its CarePort Health business to WellSky Corp. CarePort solutions assist hundreds of hospitals and post-acute care providers to efficiently coordinate and transition patients through different settings of care.
In 2020, ScienceSoft received licenses in the United Arab Emirates to offer IT services, IT solutions and IT consultancy and opened its first Middle East office in the UAE. The Middle East launch solidifies ScienceSoft’s aspiration to tap into new markets and grow international presence.
Siemens Healthineers and KlinikumLippe GmbH (KLG) had entered into a ten-year technology partnership for all the healthcare provider’s locations. The contract covers delivery and maintenance of large imaging equipment and ultrasound units.
Some of the prominent players in the global US complex & chronic condition management market include:
Segments Covered in the Report
By Disease Type
PROCEED TO BUY :
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client